TRANSLATION INTO BRAZILIAN PORTUGUESE, CULTURAL ADAPTATION AND VALIDATATION OF THE SYSTEMIC LUPUS ERYTHEMATOSUS QUALITY OF LIFE QUESTIONNAIRE [SLEQOL] by Freire, Eutilia Andrade Medeiros et al.
ÓRGÃO OF IC IAL DA SOC IEDADE PORTUGUESA DE REUMATOLOGIA - ACTA REUMATOL PORT. 2010;35:334-339
334
A R T I G O O R I G I N A L
T R A N S L AT I O N I N T O B R A Z I L I A N P O R T U G U E S E ,  
C U LT U R A L A D A P TAT I O N A N D VA L I D ATAT I O N
O F T H E S Y S T E M I C L U P U S E R Y T H E M AT O S U S
Q U A L I T Y O F L I F E Q U E S T I O N N A I R E ( S L E Q O L )
Freire EAM*,**,***, Bruscato A***,****, Leite DRC*, Sousa TTS*, Ciconelli RM**,***
*Department of Internal Medicine, Federal University of Paraíba
UFPB
**Department of Internal Medicine, Federal University 
of São Paulo UNIFESP
***Member of the Pronuclear Project, Brazilian Rheumatology 
Society
****Insper Institute of Education and Research, São Paulo
increasingly taken into account for chronic disea-
ses. To date there are no tools to assess Quality of
Life in Systemic Lupus Erythematosus (SLE) writ-
ten in the Portuguese language. The questionnaire
is valid and reliable for SLE patients in Brazil. 
Keywords: Systemic Lupus Erythematosus; Qua-
lity of Life; Translations; Reproducibility of Results.
Introduction
Prevalence of Systemic Lupus Erythematosus (SLE)
is increasing and SLE mortality is decreasing. The
most important component of SLE medical care is
to reduce the consequences and disabilities asso-
ciated with SLE, bearing in mind both health rela-
ted quality of life issues as well as longevity. The
main objective of medical treatment is to reduce di-
sabilities and defficiencies1. The quality of life as-
sessment is based on applying tools or questionnai-
res that, for the most part, were originally written
in English and focus on the English speaking popu-
lation. Therefore these tools must be translated be-
fore they can be applied in another language, and
the assessment properties demonstrated within a
specific cultural context2-6. Scales that assess qua-
lity of life measure the changes in physical, psycho-
logical and social function as a result of disease,
and reflect the patient’s perception of his or her
health. Generic quality of life instruments are valid
for measuring the quality of life of SLE patients and
enable comparison across a range of rheumatic di-
seases. However, critics argue that such tools are
not adequately understood by the patients1,7. Spe-
cific quality of life scales include domains that are
important for a specific disease. With respect to
SLE, these domains must assess disease progress,
the extent or patient organ involvement and their
response to treatment8.
In 2005 LEONG et al. published a paper describing
Abstract
Objectives: Translate into Brazilian Portuguese,
cross cultural adaptation and assess the reliability
and validity of the Systemic Lupus Erythematosus
Quality of Life Questionnaire (SLEQOL). 
Material and Methods: Study population: 107 SLE
patients, answered the SLEQOL questionnaire.
Translation: into Portuguese and cross-cultural
adaptation was performed in accordance with stu-
dies on questionnaire translation methodology into
other languages. Reliability: Was analyzed using
three interviews with different interviewers, two on
the same day (interobserver) and the third within
14 days of the first assessment (intraobserver). Va-
lidity: Validity was assessed by correlating clinical
and quality of life parameters with the SLEQOL.
Statistical analysis: A descriptive analysis of the
study sample. Reproducibility was assessed using
an intraclass correlation coefficient (ICC). Internal
consistency was assessed using Cronbach’s alpha
coefficient. To assess validity we used Pearson’s cor-
relation coefficient. Five percent was the level of
significance adopted for all statistical tests. 
Results: The SLEQOL was translated and culturally
adapted. The main findings were: a 0.807 internal
consistency correlation coefficient for all questions
and domains. The inter and intraobserver correla-
tion coefficients were 0.990 and 0.969 respectively.
Validation showed good correlation with theSF-36
and poor correlation with lupus activity or dama-
ge indices. 
Conclusions: The quality of life parameter has been
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the development and preliminary validation of a
specific Systemic Lupus Erythematosus Quality of
Life questionnaire in English (SLEQOL). This ques-
tionnaire is made up of 40 items split into six do-
mains: physical function, occupational activity,
symptoms, treatment, mood and self-image. Each
domain score varies from 1 to 7, with higher sco-
res indicating poorer quality of life. Total scores
vary between a low of 40 and a high of 280. The
questionnaire was applied to 275 SLE patients and
demonstrated good internal consistency, a Cron-
bach's alpha of 0.95 and intraobserver reproduci-
bility of 0.83. Responsiveness was tested using a
global assessment scale that varies between +7 and
-7, submitted to statistical calculations that assess
responsiveness, demonstrating that the SLEQOL
questionnaire is more sensitive to changes over
time9 than the Short Form-36 (SF-36. a generic ins-
trument). This questionnaire has not yet been
translated into, or validated in Brazilian Portugue-
se. This then became the objective of our study, es-
pecially in light of the fact that there are no Portu-
guese language quality of life questionnaires spe-
cific for SLE.
The objective of this effort is to translate the
SLEQOL into Brazilian Portuguese, culturally adapt
it and check its measurement properties so that it
may be applied as a quality of life assessment tool
to Brazilian SLE patients.
Material and Methods
One hundred and seven SLE patients over the age
of 16, who fulfill the American College of Rheuma-
tology10 diagnostic criteria, do not present any cog-
nitive impairment and signed the Term of Consent
is accepted for this study. In order to be eligible for
this study patients had to be clinically stable so as
not to be submitted to any change in medication
or other procedure for a period of 15 days or less,
thus enabling an assessment of the questionnaire
reproducibility. All of these patients were outpa-
tient clinics randomly selected from the Rheuma-
tology Clinic at Hospital São Paulo, UNIFESP or in
the Rheumatology Clinic at Hospital Universitá-
rio, UFPB. Patients with other inflammatory disea-
ses, fibromyalgia and hypothyroidism were exclu-
ded from the study. These diseases are excluded
through clinical examination and laboratorial data.
In addition to an overall assessment of the patient’s
health by the patient and her physician, a protocol
listing clinical and demographic characteristics
was applied and disease activity measured using
SLEDAI- 2K11 and BILAG12;chronic damage was as-
sessed using SLICC/ACR DI13 and Quality of Life 
using SF-362.
Translation and Cultural Adaptation: The me-
thodology for translation and cultural adaptation
of these questionnaire was based on previous work
discussing methodology used to translate the
questionnaire into other languages4-6.
Initial translation: the questions in the English
language version of the SLEQOL questionnaire
were translated into Brazilian Portuguese by two
independent English language teachers, both Bra-
zilian and both aware of the objectives of the sur-
vey. We stressed that the translation should be con-
ceptual, rather than strictly literary. Both transla-
tions were compared by the translators themselves
and by the study coordinator and, where there were
differences, adjustments were made until a con-
sensus was reached for the initial version (Version
1 in Portuguese).
Assessment of the initial translation: Version 1
in Portuguese was back translated by two different
English language teachers, also Brazilian, who had
not participated in the previous steps of this study.
The back translation was compared to the original
questionnaire in English and a committee ana-
lyzed the differences. Where necessary the state-
ments or questions in Portuguese were rewritten
until a consensus was reached, thus generating
Version 2 in Portuguese.
Assessment of the Cultural Equivalence (pre-
testing): The questionnaire was applied to a group
of ten SLE patients randomly selected from the
Rheumatology Outpatient Clinic at Hospital São
Paulo. To each of the study questions we added the
option "does not apply” to find questions that were
not understood or that were not truly relevant to
our population and therefore culturally inappro-
priate. Questions considered to be "not applicable"
25% or more of the time were selected and ana-
lyzed by a group of researchers trying to obtain a
consensus and replace these questions with oth-
ers similar in concept so as not to significantly
change the structure and assessment properties of
the question. These changes generated a new ver-
sion (Version 3 in Portuguese) This version was re-
plicated until no more than 15% of the patients
considered any single item to be "not applicable”.
Assessment of questionnaire measurement
properties: Reliability was analyzed based on three
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interviews as follows: Two interviews were conduc-
ted by two separate interviewers (1 and 2) on the
same day (interobserver), and a third interview was
conducted by interviewer 1 within no more than 14
days following the first assessment (intraobserver)
with the same patients; item consistency within
the questionnaire was also assessed. All of the in-
terviews were conducted at the same time of day.
Validation: Questionnaire validation was asses-
sed by checking the relationship between its six
domains scores , with higher scores indicating po-
orer quality of life and total scores vary between a
low of 40 and a high of 280, and the scores obtai-
ned using existing quality of life questionnaires
such as SF-36 where in each of eight domains sco-
res varies from 0 to 100, with higher scores indica-
ting best quality of life , and other clinical parame-
ters such as disease activity by SLEDAI 2K and BI-
LAG scores, Overall Physician and patient As-
sessment and severity by SLICC/ACR damage
index during the assessment.
Statistical analysis: A descriptive analysis to
characterize sample demographics and clinical
status. Patient responses were evaluated using ave-
rages and standard deviations. To assess intraob-
server reproducibility we calculated the intraclass
correlation coefficient (ICC). Internal consistency
of questionnaire items was assessed using Cron-
bach’s alpha (Cronbach 1951). Validation was as-
sessed using Pearson’s correlation coefficient
between quality of life questionnaires SLEQOL and
SF-36, and other disease activity and severity pa-
rameters such as SLEDAI 2K ,BILAG, Overall Physi-
cian and patient Assessment and SLICC/ACR DI .
Five percent was the level of significance adopted
for all statistical tests.
Results
107 SLE patients were assessed. Their socioecono-
mic and demographic characteristics are described
in Table I. In all cases we used an interviewer to ap-
ply the questionnaire, given the socio-cultural le-
vel of the study population. During the cultural
equivalence phase (pre testing) we found it hard to
explain the scores (1 through 7) for each question,
which required a bit more time when applying the
questionnaire. Given that question 6 elicited more
than 15% of "do not understand" responses, for
physical function we replaced "walk for 3 km" with
"walk for 1 hour". In question 7 and 8 under the oc-
Table I. Clinical and socio-demographic 
characteristics of 107 SLE patients
Gender
Female n (%) 99 (99.5)
Male n (%) 8 (7.5)
Age (years)
Average, SD 36.8; 12 
Minimum-Maximum 17-68 
Disease duration (years)
Average, SD 5.9; 5.6
Minimum-Maximum 0.8-45 
Race (%)
White 46 (43)
Non white 61 (57)
Education (years of schooling)
Average, SD 6.7; 3
Minimum - Maximum 3-16 
Income (US Dollars)
Average, SD 120; 80
Minimum-Maximum 60-220
cupational activity domain we switched “perfor-
mance” and "interference” with “domestic chores
or work outside the home” and “hampered career
or education”. In question 28 under mood we re-
placed “self consciousness" with "feels different
from other people" and in question 34, under self
image, we replaced "low self esteem" with “felt in-
ferior to others”. Once changed, the questions were
considered to be appropriate or culturally equiva-
lent by more than 95% of the patients and by the
panel of experts that supported this project. The
average time to apply the questionnaire was 10 mi-
nutes. Table II has the average value for each of the
SLEQOL questionnaire components. The worst
scores were in the “self image” and “occupational
activity” domains and the best were in “treatment”
and “mood” domains. In terms of the correlation
coefficients, the internal consistency coefficient
was 0.807 on average for all questions and doma-
ins; interobserver correlation was 0.990 and inte-
robserver correlation 0.969 (Table III).
A total of 107 patients filled out the clinical pro-
tocol to assess validation. We correlated the ques-
tionnaire with the clinical and Quality of Life me-
asurements already validated and in common use.
By convention correlations may be positive or ne-
gative. According with Leong and colleagues we
considered very strong correlations those with r >
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Table II. Values obtained for the SLEQOL questionnaire and domains applied to 107 SLE patients
Minimum Maximum Average SD
SLEQOL
Domains
Total Score 42 260 116 52
Physical Function 6 40 14.5 9.9
Occupational Activity 9 57 19.7 10.6
Symptoms 8 40 17.8 8.4
Treatment 4 25 10.4 5.1
Mood 4 28 11 5.7
Self Image 9 60 22,1 12
Table III. SLEQOL internal consistency and 
reproducibility in 50 patients assessed using 
an intraclass correlation coefficient and 
Cronbach's alpha
Correlation coefficients SLEQOL
Intraobserver 0.969
Interobserver 0.990
Internal Consistency 0.807 Total
0.807 by domain
p< 0.001
7, as strong those with r =0.4 to 0.69, as moderate
those with r = 0.3 to 0.39 and as poor those with 
r = 0.20 to 0.29, and established the level of corre-
lation found.
Table IV shows the correlation between SLEQOL
and activity, damage and quality of life indicators.
There was a strong correlation between the total
score of SLEQOL and SF-36 for physical and emo-
tional issues. In terms of mood and self image do-
mains, there was a strong correlation between 
SLEQOL and SF-36 for emotional issues. All other
SLEQOL domains correlated poorly with the SF-36
domains.
Regarding the activity criteria, the symptoms,
treatment and self image domains of SLEQOL
showed moderate correlation with disease activity
measured using SLEDAI 2K, which was not the case
with BILAG.
The overall health assessment by a physician
showed strong correlation with the overall 
SLEQOL score, but within the domains correlation
was poor. The patient’s global health assessment
showed strong correlation with the total SLEQOL
score as well as with the activities and self image do-
mains.
Chronic damage showed strong correlation with
total SLEQOL score, but moderate and poor with
the domains.
Discussion
Patient perception of their health and quality of life,
as well as the impact of the disease and treatment
on their life is being broadly recognized as a topic
of research in clinical and epidemiological studies.
However, most of the tools used to assess quality of
life in these patients can only be found in English.
Experts agree that translating these tools to ano-
ther language must not only be accurate, but that
it is also important to test the psychometric mea-
surements in a specific cultural context. Each soci-
ety has its own sets of beliefs, attitudes, habits, be-
haviors and social values. These give people a sen-
se of identity, how they should behave and conse-
quently what they should and should not do. These
rules or concepts reflect and distinguish the cultu-
re of a given country. When we proposed to trans-
late a questionnaire, it should be presented in sim-
ple language that is easy to understand and remain
equivalent in terms of the cultural concepts2. The
differences in terms of culture and lifestyle make it
difficult to find exact equivalents for a number of
terms, which is why the translation must be care-
fully done and thoroughly tested in the new envi-
ronment14.
The SLEOQL was developed by Leong et al.9 in
English. I reported the problems our patients had
in understanding the questionnaire in a personal
communication with the author, primarily due to
 
ÓRGÃO OF IC IAL DA SOC IEDADE PORTUGUESA DE REUMATOLOGIA - ACTA REUMATOL PORT. 2010;35:334-339
338
SYSTEMIC LUPUS ERYTHEMATOSUS QUALITY OF LIFE QUESTIONNAIRE
the socio-intellectual level of our patients compa-
red to those in Singapore.We had the author’s sup-
port in all phases of the translation and cultural
adaptation of the questionnaire. 
Leong et al. (2005) achieved similar results to
ours in terms of the highest scores in the "occupa-
tional activity” and “self image” domains. This is
likely due to the fact that active SLE is an incapa-
citating disease that also changes the patient’s ap-
pearance, in addition to the side-effects of treat-
ment with steroids and immune suppressants. The
better results in the Treatment and Mood domains
may reflect a component of patient adaptation to
the disease. 
Every assessment instrument should be repro-
ducible over time – in other words, it should pro-
duce equal or very close results in two or more ins-
tances with the same patients, evidently assuming
no change in clinical status. Test-retest reproduci-
bility has been demonstrated. The internal consis-
tency of the Portuguese language of the SLEQOL,
assessed by the correlation between the various
questions proved to be adequate, with a coefficient
of 0.8. This is an important observation as some of
the questions were altered. In the translation and
cultural adaptation to Chinese, the SLEQOL items
in English could be precisely translated into Chi-
nese, so the translation proceeded smoothly. Once
translated, the SLEQOL-C was applied to 638 pa-
tients with no problem in terms of understanding
the questions15.
The fact that during the validation process the
questionnaire correlated only moderately with di-
sease activity and damage is consistent with other
publications16. This suggests the possibility that ac-
tivity and damage do not directly interfere in qua-
lity of life, as in the patient's overall health as-
sessment the correlations were better than with
these indicators were already established, or it
could be that they truly do not capture this facet of
the disease. A possible explanation might be adap-
tation to chronic disease or the type of personality
influencing the subjective perception of overall
quality of life17.
Gladman (2006) reported that, during the past
two decades a number of tools have been develo-
ped to assess SLE activity and damage, however
quality of life has been assessed using a generic
tool. Recently SF-36 has been shown not to be very
sensitive to changes18, which is why its use in cli-
nical trials has been questioned. The author goes
on to state that specific tools to assess quality of life
in SLE patients are necessary, such as the SLEQOL
that has been well tested in terms of its measure-
* P < 0.05; **P < 0.01; ***P < 0.001
Table IV. Assessment of the correlation between SLEQOL, including its domains and SF-36. SLEDAI, overall
Physician Assessment, overall Patient Assessment, BILAG and SLICC/ACR DI in 107 SLE patients
SLEQOL
Total Physical Self 
SF-36 Score Function Activities Symptoms Treatment Mood Image
Physical Functioning 0.008 0.166 0.188 - 0.264** - 0.202* 0.12 0.16
Role Physical - 0.573*** -0.222* 0.077 0.125 0.035 0.05 0.04
Bodily Pain 0.145 0.026 0.123 - 0.232** - 0.275** 0.14 0.08
General Health 0.141 0.022 0.109 0.153 0.153 0.08 0.11
Vitality 0.120 0.128 0.104 - 0.221* 0.158 0.058 0.071
Social functioning - 0.240** 0.012 0.076 0.171 0.164 0.094 0.090
Role Emotional - 0.450*** - 0.270* 0.005 0.152 - 0.210* - 0.531*** - 0.780***
Mental Health 0.125 0.018 0.160 - 0.225* - 0.250* - 0.271** 0.130
SLEDAI 2K 0.001 0.110 0.190 0.361* 0.385* 0.231* 0.380*
Overall Physician - 0.480*** - 0.240** - 0.281* - 0.230* 0.150 0.181 - 0.270*
Assessment
Overall Patient 
Assessment - 0.482*** - 0.290* - 0.430*** - 0.291* - 0261* - 0.382* - 0.401*
BILAG 0.250* 0.120 0.181 0.241* 0.010 0.183 0.170
SLICC/ACR DI 0.412* 0.340* 0.310* 0.030 0.221* 0.190 0.210*
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ment properties, and encourages that it be applied
and validated with other populations19. 
In conclusion, we have translated, culturally
adapted, checked the reliability and validated the
SLEQOL using international methodology and de-
monstrated that the questionnaire is valid and re-
producible. Studies are already underway to de-
monstrate this instrument’s sensitivity to change. 
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